Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Annals of Oncology
Published October 23, 2026
Perioperative pembrolizumab or placebo plus neoadjuvant cisplatin and gemcitabine in participants...
October 24, 2026
Medspoke
Medspoke
Annals of Oncology
Published October 23, 2026
00:00
--:--
Capivasertib plus abiraterone in PTEN-deficient de novo metastatic hormone-sensitive prostate can...
October 24, 2026
Share
Capivasertib plus abiraterone in PTEN-deficient de novo metastatic hormone-sensitive prostate cancer: updated survival analysis from CAPItello-281.
https://www.medspoke.co/channel_journal?id=686&tap_id=16234
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Open Forum Infectious Diseases
Published October 21, 2026
Etiology and Outcomes of Bloodstream Infections by Immunosuppression Type: A Population-Based Lab...
October 24, 2026
Why are you reporting this TALK?
